Dr Agarwals Eye Hospital Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 22.28% vs 16.90% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 35.46% vs 22.32% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 16.51% vs 18.21% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is -33.41% vs 37.29% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Dr Agarwal's Eye With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

142.97

406.15

-263.18

-64.80%

Other Operating Income

0.00

Total Operating income

142.97

406.15

-263.18

-64.80%

Raw Material Cost

0.00

70.13

-70.13

-100.00%

Purchase of Finished goods

14.66

0.00

14.66

(Increase) / Decrease In Stocks

-1.06

0.00

-1.06

Employee Cost

27.48

72.96

-45.48

-62.34%

Power Cost

0.00

Manufacturing Expenses

36.21

111.15

-74.94

-67.42%

Selling and Distribution Expenses

0.00

Other Expenses

22.42

72.10

-49.68

-68.90%

Total Expenditure (Excl Depreciation)

99.71

326.34

-226.63

-69.45%

Operating Profit (PBDIT) excl Other Income

43.26

79.81

-36.55

-45.80%

Other Income

1.96

8.42

-6.46

-76.72%

Operating Profit (PBDIT)

45.22

88.23

-43.01

-48.75%

Interest

2.77

1.65

1.12

67.88%

Exceptional Items

0.00

Gross Profit (PBDT)

42.45

86.58

-44.13

-50.97%

Depreciation

11.49

11.76

-0.27

-2.30%

Profit Before Tax

30.96

74.82

-43.86

-58.62%

Tax

7.58

18.97

-11.39

-60.04%

Provisions and contingencies

0.00

Profit After Tax

23.38

55.85

-32.47

-58.14%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

23.38

55.85

-32.47

-58.14%

Equity Capital

4.83

91.67

-86.84

-94.73%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

48.41

6.09

42.32

694.91%

Diluted Earnings per share

48.38

6.09

42.29

694.42%

Operating Profit Margin (Excl OI)

30.26%

19.65%

0.00

10.61%

Gross Profit Margin

29.69%

21.32%

0.00

8.37%

PAT Margin

16.35%

13.75%

0.00

2.60%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 142.97 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 19.13% vs 3.26% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 22.28% vs 16.90% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 23.38 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 43.97% vs -6.02% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 35.46% vs 22.32% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 43.26 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 28.25% vs -1.86% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 16.51% vs 18.21% in Jun 2025

Quarterly - Interest

Interest 2.77 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 41.33% vs -3.45% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -33.41% vs 37.29% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 30.26%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025